A Study of LY2484595 in Japanese Subjects

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

Also called NCT01375075

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 165 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01375075
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01375075. Randomized; quadruple masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2018-10-25.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of LY2484595 in Japanese Subjects
Condition
Dyslipidemias
Intervention (Drug)
LY2484595
Intervention (Drug)
Placebo
Intervention (Drug)
Atorvastatin
Lead sponsor
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct01375075
Content hash
ee86856810f822f1e94883dc6b5e7bcc32a1e39bc76aba26ab9d9d3440b7d29d